These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10425382)

  • 21. Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating esters and amides of 3- and 4-carboxybenzolamide.
    Casini A; Scozzafava A; Mincione F; Menabuoni L; Starnotti M; Supuran CT
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2867-73. PubMed ID: 14611846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties.
    Mincione F; Starnotti M; Menabuoni L; Scozzafava A; Casini A; Supuran CT
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1787-91. PubMed ID: 11425561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors: synthesis of water soluble sulfonamides incorporating a 4-sulfamoylphenylmethylthiourea scaffold, with potent intraocular pressure lowering properties.
    Casini A; Scozzafava A; Mincione F; Menabuoni L; Supuran CT
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):333-43. PubMed ID: 12683750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors with strong topical antiglaucoma properties incorporating a 4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide scaffold.
    Casini A; Mincione F; Vullo D; Menabuoni L; Scozzafava A; Supuran CT
    J Enzyme Inhib Med Chem; 2002 Feb; 17(1):9-18. PubMed ID: 12365464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides--a novel class of intraocular pressure lowering agents.
    Mincione F; Menabuoni L; Briganti F; Mincione G; Scozzafava A; Supuran CT
    J Enzyme Inhib; 1998 Jul; 13(4):267-84. PubMed ID: 9795865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors. Part 60(#). The topical intraocular pressure-lowering properties of metal complexes of a heterocyclic sulfonamide: influence of the metal ion upon biological activity.
    Supuran CT; Scozzafava A; Mincione F; Menabuoni L; Briganti F; Mincione G; Jitianu M
    Eur J Med Chem; 1999; 34(7-8):585-95. PubMed ID: 11278044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclodextrin complexes of sulfonamide carbonic anhydrase inhibitors as long-lasting topically acting antiglaucoma agents.
    Maestrelli F; Mura P; Casini A; Mincione F; Scozzafava A; Supuran CT
    J Pharm Sci; 2002 Oct; 91(10):2211-9. PubMed ID: 12226848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
    Sugrue MF
    J Ocul Pharmacol Ther; 1996; 12(3):363-76. PubMed ID: 8875343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors. Arylsulfonylureido- and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I.
    Scozzafava A; Supuran CT
    J Enzyme Inhib; 1999; 14(5):343-63. PubMed ID: 10488246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Schwam H; Baldwin JJ; Christy ME; Ponticello GS
    J Ocul Pharmacol; 1990; 6(1):9-22. PubMed ID: 2362161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating 2,4,6-trisubstituted-pyridinium-ethylcarboxamido moieties possessing membrane-impermeability and in vivo selectivity for the membrane-bound (CA IV) versus the cytosolic (CA I and CA II) isozymes.
    Supuran CT; Scozzafava A; Ilies MA; Briganti F
    J Enzyme Inhib; 2000; 15(4):381-401. PubMed ID: 10995069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits.
    Winum JY; Casini A; Mincione F; Starnotti M; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jan; 14(1):225-9. PubMed ID: 14684332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
    Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT
    J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of carbohydrate-based sulphonamide derivatives as topical antiglaucoma agents through selective inhibition of carbonic anhydrase II.
    Hou Z; Li C; Liu Y; Zhang M; Wang Y; Fan Z; Guo C; Lin B; Liu Y
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):383-390. PubMed ID: 31865756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes.
    Scozzafava A; Briganti F; Ilies MA; Supuran CT
    J Med Chem; 2000 Jan; 43(2):292-300. PubMed ID: 10649985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route.
    Maren TH; Bar-Ilan A; Conroy CW; Brechue WF
    Exp Eye Res; 1990 Jan; 50(1):27-36. PubMed ID: 2307193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors. Preparation of potent sulfonamides inhibitors incorporating bile acid tails.
    Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1551-7. PubMed ID: 12039560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes.
    Supuran CT; Scozzafava A; Saramet I; Banciu MD
    J Enzyme Inhib; 1998 Jun; 13(3):177-94. PubMed ID: 9629536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thieno[2,3-b]furan-2-sulfonamides as topical carbonic anhydrase inhibitors.
    Hartman GD; Halczenko W; Prugh JD; Smith RL; Sugrue MF; Mallorga P; Michelson SR; Randall WC; Schwam H; Sondey JM
    J Med Chem; 1992 Aug; 35(16):3027-33. PubMed ID: 1501230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.